ClinicalTrials.gg
Sign In
Not yet recruitingNCT07894094THRIVE Phase 1Updated Oct 26, 2026

Phase 1: Thrive Together: A Feasibility and Acceptability Evaluation of Peer Mentoring for High Schoolers With ADHD and Their Caregivers

An observational study in Attention-Deficit/Hyperactivity Disorder (ADHD), sponsored by Boston Children's Hospital. Not yet recruiting at 1 site in United States. Open to participants aged 13 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-10-26.

Sponsored by Boston Children's Hospital · Observational

Updated Oct 26, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
40
Ages
13 Years to 18 Years
Sex
All
01

Study summary

During this first phase of the study, we are conducting focus group to conduct a needs assessment. Specifically, we will be holding focus groups with adolescents with ADHD as well as separate focus groups with the adolescents' parents to better understand the current needs of youth with ADHD and how to best support them.

Read the detailed description

Attention deficit hyperactivity disorder (ADHD) is a common chronic childhood condition, affecting approximately 10% of youth in the U.S. Despite advancements in evidence-based pharmacological and behavioral treatments, youth with ADHD continue to experience significant functional impairment across multiple domains. This Pilot Project, THRIVE (Thriving with Healthy Routines, Interpersonal Skills, and ExecutiVE-Functioning), will improve access to evidence-based psychoeducation and social support for families through the implementation and evaluation of a peer-facilitated support group intervention for youth with ADHD and their caregivers. In Phase 1 of this study, we will collaborate with youth with ADHD and their caregivers to refine our evidence- informed curriculum, ensuring that content, format, and delivery are responsive to their lived experiences.

02

Conditions studied

  • Attention-Deficit/Hyperactivity Disorder (ADHD)

Keywords

  • Attention-Deficit/Hyperactivity Disorder (ADHD)
  • Focus groups
  • Needs assessment
  • youth and families
03

In context

Attention Deficit Disorder with Hyperactivity

1,548 studies on the registry are indexed under Attention Deficit Disorder with Hyperactivity; 254 are open to participants now.

This study's planned enrollment of 40 is below the median of 140 across 271 observational studies indexed under Attention Deficit Disorder with Hyperactivity.

Browse Attention Deficit Disorder with Hyperactivity studies →

Lead sponsor

Boston Children's Hospital is the lead sponsor of 608 studies on the registry; 149 are open to participants now.

Of its 33 completed or terminated interventional studies of FDA-regulated products, 19 (58%) have results posted.

Browse Boston Children's Hospital studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

We will be recruiting 13-17 year old youth with ADHD as well as their caregivers.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ADHD diagnosis, English speaking, available on date of focus group, Resident in MA

Exclusion criteria

Exclusion Criteria:

  • Intellectual Disability diagnosis, Autism Spectrum Disorder diagnosis, in Department of Children and Families custody, Caregiver not available,
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
40 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Rapid qualitative analysis

    We will conduct a rapid qualitative analysis in order to synthesize the qualitative feedback from the focus groups

    Time frame: 2 months

07

Study locations

1 site
08

References and documents

Publications

  • Bibliography: 1. Danielson, M.L., et al., ADHD Prevalence among US children and adolescents in 2022: Diagnosis, severity, co-occurring disorders, and treatment. Journal of Clinical Child & Adolescent Psychology, 2024: p. 1-18. 2. Evans, S.W., et al., Evidence-based psychosocial treatments for children and adolescents with attention deficit/hyperactivity disorder. Journal of Clinical Child & Adolescent Psychology, 2018. 47(2): p. 157-198. 3. Mechler, K., et al., Evidence-based pharmacological treatment options for ADHD in children and adolescents. Pharmacology & Therapeutics, 2022. 230: p. 107940. 4. Arnold, L.E., et al., Long-term outcomes of ADHD: Academic achievement and performance. Journal of Attention Disorders, 2020. 24(1): p. 73-85. 5. Dodds, M., et al., Economic burden and service utilization of children with Attention-Deficit/Hyperactivity disorder: a systematic review and Meta-analysis. Value in Health, 2024. 27(2): p. 247-264. 6. Harstad, E.B., et al., Children with ADHD are at risk for a broad array of adverse adult outcomes that cross functional domains: Results from a population-based birth cohort study. Journal of attention disorders, 2022. 26(1): p. 3-14. 7. Meyer, J., et al., Associated predictors of functional impairment among adolescents with ADHD-A cross-sectional study. Child Adolescent Psychiatry and Mental Health, 2022. 16(1): p. 29. 8. Overgaard, K.R., et al., Functional impairment related to ADHD from preschool to school age. Journal of Attention Disorders, 2025. 29(3): p. 220-230. 9. Ros, R. and P.A. Graziano, Social functioning in children with or at risk for attention deficit/hyperactivity disorder: A meta-analytic review. Journal of Clinical Child & Adolescent Psychology, 2018. 47(2): p. 213-235. 10. Zhao, X., et al., Family burden of raising a child with ADHD. Journal of Abnormal Child Psychology, 2019. 47: p. 1327-1338. 11. Roizen, N.J., et al., Adaptive functioning in children with attention-deficit hyperactivity disorder. Arch Pedia

Individual participant data

Plan to share: No

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 26, 2026
Show all 1 update
  1. Oct 26, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07894094
Lead sponsor
Boston Children's Hospital
Collaborators
YMCA
Responsible party
Virginia Peisch (Psychologist, Boston Children's Hospital) — Principal investigator
First posted
Oct 26, 2026
Start date
Oct 31, 2026 (estimated)
Primary completion
Feb 1, 2027 (estimated)
Completion
Mar 1, 2027 (estimated)
Last update
Oct 26, 2026

Study contacts

Virginia D Peisch, PhD
Contact
virginia.peisch@childrens.harvard.edu
774-487-4092

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Attention Deficit Disorder with Hyperactivity →

Other studies from this sponsor

Boston Children's Hospital →

Start the discussion